Mesoblast and Big Pharma...., page-18

Thanks for that @mattycee1, I didn't watch the replay, having stayed the distance but maybe now I will try to catch up to when the Patients Advocate realised the big whoopsy, never did get past much more than the original vote and how they voted when it cut out. That was exciting enough, we were genuinely on edge here.

And thinking about it there was a really insightful remark the bloke from the MAGIC consortium made about their contemporaneous data set that I would like to listen to again, in his final answer I think, got at least one Oh of understanding from the panel. At least some of the highly experienced ODAC panel had a continuous learning curve that day and they were not afraid to say so.